Rigel Pharmaceuticals, Inc.

Investors News & Events Contact Us
  • Home
  • Who We Are
    • Company Overview
    • Management Team
    • Board of Directors
    • Partners
  • Pipeline
    • Clinical Programs
    • IRAK1/4
    • RIPK1
    • Partnered Programs
    • Clinical Trials
    • Investigator Sponsored Research
    • Expanded Access Policy
  • Products
  • Join Our Team
    • Life at Rigel
    • Our Values
    • Benefits
    • Current Openings
  • Investors
  • News & Events
  • Contact Us

Financial Results

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
    • Email Alerts
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • FAQ
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Analyst Coverage
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • ESG
  • Financial Info

  • Financial Results
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • FAQ

2025

Q1 2025

Quarter Ended Mar 31, 2025
Earnings Release
PDF HTML
Audio
Earnings Webcast
Earnings Presentation
PDF
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2024

FY 2024

Fiscal Year Ended Dec 31, 2024
Earnings Release
PDF HTML
Earnings Presentation
PDF
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2024

Quarter Ended Sep 30, 2024
Earnings Release
PDF HTML
Earnings Presentation
PDF
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2024

Quarter Ended Jun 30, 2024
Earnings Release
PDF HTML
Earnings Presentation
PDF
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2024

Quarter Ended Mar 31, 2024
Earnings Release
PDF HTML
Earnings Presentation
PDF
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2023

FY 2023

Fiscal Year Ended Dec 31, 2023
Earnings Release
PDF HTML
Earnings Presentation
PDF
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2023

Quarter Ended Sep 30, 2023
Earnings Release
PDF HTML
Earnings Presentation
PDF
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2023

Quarter Ended Jun 30, 2023
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2023

Quarter Ended Mar 31, 2023
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2022

FY 2022

Fiscal Year Ended Dec 31, 2022
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2022

Quarter Ended Sep 30, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2022

Quarter Ended Jun 30, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2022

Quarter Ended Mar 31, 2022
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2021

FY 2021

Fiscal Year Ended Dec 31, 2021
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2021

Quarter Ended Sep 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2021

Quarter Ended Jun 30, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2021

Quarter Ended Mar 31, 2021
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2020

FY 2020

Fiscal Year Ended Dec 31, 2020
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2020

Quarter Ended Sep 30, 2020
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2020

Quarter Ended Jun 30, 2020
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2020

Quarter Ended Mar 31, 2020
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2019

FY 2019

Fiscal Year Ended Dec 31, 2019
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2019

Quarter Ended Sep 30, 2019
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2019

Quarter Ended Jun 30, 2019
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2019

Quarter Ended Mar 31, 2019
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2018

FY 2018

Fiscal Year Ended Dec 31, 2018
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2018

Quarter Ended Sep 30, 2018
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2018

Quarter Ended Jun 30, 2018
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2018

Quarter Ended Mar 31, 2018
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2017

FY 2017

Fiscal Year Ended Dec 31, 2017
Earnings Release
PDF HTML
10-K Filing
PDF HTML
10-K/A Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2017

Quarter Ended Sep 30, 2017
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2017

Quarter Ended Jun 30, 2017
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2017

Quarter Ended Mar 31, 2017
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2016

FY 2016

Fiscal Year Ended Dec 31, 2016
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2016

Quarter Ended Sep 30, 2016
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2016

Quarter Ended Jun 30, 2016
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2016

Quarter Ended Mar 31, 2016
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

2015

FY 2015

Fiscal Year Ended Dec 31, 2015
Earnings Release
PDF HTML
10-K Filing
PDF HTML
XBRL
ZIP XLS HTML

Q3 2015

Quarter Ended Sep 30, 2015
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q2 2015

Quarter Ended Jun 30, 2015
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Q1 2015

Quarter Ended Mar 31, 2015
Earnings Release
PDF HTML
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML
  • Email Alerts
  • RSS News Feed
Terms of Use Privacy Policy Your Cookie Preferences

© 2025 Rigel Pharmaceuticals, Inc. All Rights Reserved.

TAVALISSE, TAVLESSE, REZLIDHIA, GAVRETO, RIGEL and the Rigel arc logo are registered trademarks of Rigel Pharmaceuticals, Inc.

Facebook Twitter Linkedin